May 2007
The United States market for in vitro cancer diagnostics will exceed $1 billion this year and is expected to reach $2.3 billion by 2012. What are the practical implications for clinical laboratories? Find out at "From Bench to Bedside," Washington G-2 Reports’s inaugural onco-molecular diagnostics conference, which will take place from June 6 to 8 at the Sofitel San Francisco Bay Hotel and include a visit to Stanford University’s new state-of-the-art clinical laboratories.
Subscribers: click here for the full story
Non-Subscribers: click here to subscribe
|
|
|
 Archives
|
|
May 2007 - Table of Contents
